DROPSHOT THERAPEUTICS Trademark
Trademark Overview
On Thursday, August 8, 2024, a trademark application was filed for DROPSHOT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the DROPSHOT THERAPEUTICS trademark a serial number of 98688672. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, June 4, 2026. This trademark is owned by Dropshot Therapeutics LLC. The DROPSHOT THERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical services for organ perfusion, namely, gene modification; Medical services for organ perfusion via a procedure; Medical and health services in the fields of DNA analysis and testing, genetics and genetic testing; Medical diagnostic services for testing DNA, RNA, and protein samples for diseased cells; Genetic testing and diagnostic reporting for medical purposes; providing a website featuring medical information regarding genetics; Genetic medical analysis and diagnostic reporting services for medical purposes; Medical evaluation of gene modification, organ transplants, organ perfusion, regenerative medicine, and advanced therapies for purposes of guiding treatment and assessing effectiveness for patients
Genome editing reagents for research purposes; Biochemicals and biologics, namely, engineered proteins in raw material form for scientific and pharmaceutical research in the fields of gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction; Engineered proteins in raw material form for use in scientific research and analysis in the fields of genetic diseases, gene therapy, gene modification and cell therapy; chemical reagents, reagents, enzymes, as well as kits primarily comprised of enzymes and nucleotide monomers and also containing solid phase synthesis media and synthesis plates for laboratory use, all for use in scientific research specific to synthesizing polynucleotides, and more specifically for research related to amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells
Medical devices and apparatus for the delivery of therapeutic agents; Medical devices and apparatus for the delivery of therapeutic agents to the heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system; Medical apparatus, namely, blood pumping system for use in organ perfusion; Medical apparatus for perfusing organs inside or outside human bodies for use in artificial organ support; Medical apparatus for use in organ perfusion for gene modification; Testing instruments for medical diagnostic purposes, namely, medical diagnostic apparatus for analyzing the genetic characteristics of body fluids, tissue samples and liquid biopsies for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Medical apparatus for gene modification, namely, in vitro diagnostic labeled quantitative polymerase chain reaction test kits for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system disea...
Scientific research and development of therapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; scientific research in the field of gene editing technology; Scientific research and development, namely, gene modification, as well as gene regulation and gene editing, for researching and developing modified human tissue cells and pharmaceuticals; research and development of therapeutics and pharmaceuticals using gene modification and gene editing technologies; medical and scientific research in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, genetic diseases, gene therapy and cell therapy; providing medical research information and scientific research information in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, ge...
Laboratory and scientific apparatus and instruments in the nature of spectrophotometers for measuring relative DNA, RNA and protein, fluorometric quantifiers, capillary electrophoresis apparatus, gel electrophoresis apparatus, DNA and RNA fragment analyzers, thermocyclers for research use, Polymerase Chain Reaction (PCR) testing machines, real-time quantitative Polymerase Chain Reaction (qPCR) testing instruments, reverse transcription quantitative Polymerase Chain Reaction (qPCR) testing instruments, digital quantitative Polymerase Chain Reaction (qPCR) testing instruments, isothermal amplification devices for use in nucleic acid amplification, electroporators, nucleofectors, microinjection apparatus with micromanipulators, transfection instruments for delivering nucleic acids into cells, microfluidic transfection aparatus for delivering nucleic acids into cells, microfluidic droplet devices, next-generation nucleic acid sequencers, all used for storing nucleic acid molecules, and for...
Therapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Therapeutic agents, namely, chemical preparations for pharmaceutical purposes, namely, for the treatment of different heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical preparations, therapeutic agents, and therapeutic agent preparations for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical and biological preparations based on nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, gene therapy, genome editing, genome modification, cell therapy, cellular modification, tissue modification, and organ modification for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical preparations for the treatme...
General Information
| Serial Number | 98688672 |
| Word Mark | DROPSHOT THERAPEUTICS |
| Filing Date | Thursday, August 8, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, June 4, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 23, 2025 |
Trademark Statements
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Medical services for organ perfusion, namely, gene modification; Medical services for organ perfusion via a procedure; Medical and health services in the fields of DNA analysis and testing, genetics and genetic testing; Medical diagnostic services for testing DNA, RNA, and protein samples for diseased cells; Genetic testing and diagnostic reporting for medical purposes; providing a website featuring medical information regarding genetics; Genetic medical analysis and diagnostic reporting services for medical purposes; Medical evaluation of gene modification, organ transplants, organ perfusion, regenerative medicine, and advanced therapies for purposes of guiding treatment and assessing effectiveness for patients |
| Goods and Services | Genome editing reagents for research purposes; Biochemicals and biologics, namely, engineered proteins in raw material form for scientific and pharmaceutical research in the fields of gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction; Engineered proteins in raw material form for use in scientific research and analysis in the fields of genetic diseases, gene therapy, gene modification and cell therapy; chemical reagents, reagents, enzymes, as well as kits primarily comprised of enzymes and nucleotide monomers and also containing solid phase synthesis media and synthesis plates for laboratory use, all for use in scientific research specific to synthesizing polynucleotides, and more specifically for research related to amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells |
| Goods and Services | Medical devices and apparatus for the delivery of therapeutic agents; Medical devices and apparatus for the delivery of therapeutic agents to the heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system; Medical apparatus, namely, blood pumping system for use in organ perfusion; Medical apparatus for perfusing organs inside or outside human bodies for use in artificial organ support; Medical apparatus for use in organ perfusion for gene modification; Testing instruments for medical diagnostic purposes, namely, medical diagnostic apparatus for analyzing the genetic characteristics of body fluids, tissue samples and liquid biopsies for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Medical apparatus for gene modification, namely, in vitro diagnostic labeled quantitative polymerase chain reaction test kits for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; medical apparatus for gene modification, namely, in vitro diagnostic labeled digital polymerase chain reaction analyzers with disease-specific test kits for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; DNA and RNA testing apparatus for medical use; DNA sample testing apparatus for medical use; diagnostic apparatus for medical use for the detection of genetic particularities, mutations and diseases |
| Goods and Services | Scientific research and development of therapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; scientific research in the field of gene editing technology; Scientific research and development, namely, gene modification, as well as gene regulation and gene editing, for researching and developing modified human tissue cells and pharmaceuticals; research and development of therapeutics and pharmaceuticals using gene modification and gene editing technologies; medical and scientific research in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, genetic diseases, gene therapy and cell therapy; providing medical research information and scientific research information in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services on the subject of targeting genetic therapies to specific individuals; medical and scientific research on treatment of genetic diseases and disorders |
| Goods and Services | Laboratory and scientific apparatus and instruments in the nature of spectrophotometers for measuring relative DNA, RNA and protein, fluorometric quantifiers, capillary electrophoresis apparatus, gel electrophoresis apparatus, DNA and RNA fragment analyzers, thermocyclers for research use, Polymerase Chain Reaction (PCR) testing machines, real-time quantitative Polymerase Chain Reaction (qPCR) testing instruments, reverse transcription quantitative Polymerase Chain Reaction (qPCR) testing instruments, digital quantitative Polymerase Chain Reaction (qPCR) testing instruments, isothermal amplification devices for use in nucleic acid amplification, electroporators, nucleofectors, microinjection apparatus with micromanipulators, transfection instruments for delivering nucleic acids into cells, microfluidic transfection aparatus for delivering nucleic acids into cells, microfluidic droplet devices, next-generation nucleic acid sequencers, all used for storing nucleic acid molecules, and for amplification, assembly, and modification of genetic fragments, genotyping, gene modification and analysis of cells, samples and biological systems |
| Goods and Services | Therapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Therapeutic agents, namely, chemical preparations for pharmaceutical purposes, namely, for the treatment of different heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical preparations, therapeutic agents, and therapeutic agent preparations for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical and biological preparations based on nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, gene therapy, genome editing, genome modification, cell therapy, cellular modification, tissue modification, and organ modification for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations containing genetically modified cells for use in the treatment of genetic diseases and disorders; pharmaceutical preparations for detecting genetic predispositions for medical purposes; pharmaceutical preparations for gene therapy, gene editing, genome editing, and targeted gene replacement and insertion, specifically those for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; cell therapies in the nature of pharmaceutical preparations for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; gene therapy products in the nature of genetically engineered tissues for the treatment of genetic diseases and disorders |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 8, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 8, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 8, 2024 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 8, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 8, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 8, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Dropshot Therapeutics LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Portsmouth, NH 03801
US |
| Party Name | Dropshot Therapeutics LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Portsmouth, NH 03801
US |
Trademark Events
| Event Date | Event Description |
| Thursday, August 8, 2024 | NEW APPLICATION ENTERED |
| Sunday, February 23, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 24, 2025 | ASSIGNED TO EXAMINER |
| Monday, February 24, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, February 24, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, February 24, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 16, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, May 16, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, August 21, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 21, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 21, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 26, 2025 | FINAL REFUSAL WRITTEN |
| Tuesday, August 26, 2025 | FINAL REFUSAL E-MAILED |
| Tuesday, August 26, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, November 21, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, November 21, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 21, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, November 24, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 17, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 23, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 23, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 17, 2026 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, June 4, 2026 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 4, 2026 | SOU EXTENSION 1 FILED |
| Thursday, June 4, 2026 | SOU EXTENSION 1 GRANTED |
| Friday, June 5, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
